Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 9, 2021

View Archived Issues

Synthesis and optimization of LRRK2 inhibitors using a CHK1-derived crystallographic surrogate

New MAP4K4 inhibitors identified for suppressing cardiac muscle cell death

New sporadic Alzheimer's disease animal model may improve drug testing

GABA-A alpha5 PAM RO-7015738 presented for neurological disorders

Genfleet Therapeutics discovers RIP-1 inhibitors

New IRAK-4/FLT-3 inhibitors identified at PharmaBlock Sciences

Amgen describes new PRMT5 inhibitors

New EGFR mutant inhibitors identified at Betta Pharmaceuticals

New DNA vaccine shows promise against Ebola virus infection

Microglial activation and tau spreading correlate with Braak stages in AD

NIH develops PET radioligands targeting CSF-1R for neuroinflammation

ProQR and Lilly to use Axiomer RNA editing platform to target liver and nervous system disorders

Update from large animal pilot dosing study of BB-301 for oculopharyngeal muscular dystrophy

mRNA-1273 vaccine induces antibodies against SARS-CoV-2 variants

Herantis advances project to combine Nanoform's technology with rhCDNF for Parkinson's disease

Reprogramming the tumor-immunosuppressive microenvironment to control metastasis

Researchers give rationale on the development of RAF-selective MEK inhibitors for cancer

Gut bacteria accumulate multiple therapeutic drugs

PAQ and Insilico Medicine collaborate to develop therapies through autophagy-dependent degradation

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...